This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Iise Bartke - Innovator in Immunoassay Technology
Introduction
Iise Bartke is a notable inventor based in Bernried, Germany. He has made significant contributions to the field of immunoassays, particularly in the detection of melanoma. His work is characterized by a focus on high-affinity monoclonal antibodies, which play a crucial role in medical diagnostics.
Latest Patents
Iise Bartke holds a patent for an immunoassay designed for the detection of MIA (Melanoma Inhibitory Activity). This invention involves high-affinity monoclonal antibodies against MIA in its native conformation. These antibodies are instrumental in detecting malignant melanomas, thereby enhancing diagnostic capabilities in oncology.
Career Highlights
Iise Bartke is associated with Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. His work at Roche has allowed him to contribute to advancements in immunoassay technology, which is vital for early detection and treatment of cancers.
Collaborations
Throughout his career, Iise Bartke has collaborated with esteemed colleagues such as Brigitte Kaluza and Helmut Lenz. These collaborations have fostered innovation and have been pivotal in the development of effective diagnostic tools.
Conclusion
Iise Bartke's contributions to immunoassay technology, particularly through his patent for the detection of MIA, underscore his importance in the field of medical diagnostics. His work continues to impact the detection and treatment of melanoma, showcasing the vital role of innovation in healthcare.